Droperidol vs. haloperidol for abdominal pain.

Area of Science:

• Emergency Medicine
• Pharmacology
• Pain Management

Background:

• Haloperidol and droperidol are antipsychotics with emergency department applications.
• Both agents may reduce opioid requirements for undifferentiated abdominal pain (UAP).
• Limited comparative data exists for haloperidol versus droperidol in UAP management.

Purpose of the Study:

• To compare the efficacy of haloperidol and droperidol in reducing opioid (morphine milliequivalents - MME) requirements for UAP.
• To evaluate secondary outcomes including rescue medications, hospital admission, and adverse events.

Main Methods:

• Retrospective, single-center study of adult patients with UAP.
• Exclusion criteria included need for urgent surgery or treatment for agitation.
• Primary outcome: difference in MME administered; Secondary outcomes: rescue medications, admission, length of stay, adverse effects.

Main Results:

• 100 patients (50 haloperidol, 50 droperidol) were analyzed.
• Haloperidol group received significantly lower median MME (0) than droperidol group (10) (p=0.033).
• No significant differences observed in secondary outcomes, including safety events.

Conclusions:

• Haloperidol demonstrated a significant reduction in MME for UAP compared to droperidol.
• High-quality studies are required to validate haloperidol's role in multimodal pain management for UAP.